食品科学 ›› 2024, Vol. 45 ›› Issue (17): 42-51.doi: 10.7506/spkx1002-6630-20231027-238

• 食品化学 • 上一篇    下一篇

总状蕨藻盾叶变种寡糖的酶解制备及其免疫调节活性的作用机制

曾瑾子, 林倩敏, 许静宜, 徐宝军, 黄耀南, 黄日明   

  1. (1.华南农业大学食品学院,广东 广州 510642;2.北京师范大学-香港浸会大学联合国际学院生命科学系,广东 珠海 519087;3.澳门科技大学医学院,澳门 999078)
  • 出版日期:2024-09-15 发布日期:2024-09-09
  • 基金资助:
    国家自然科学基金国际(地区)合作与交流项目(32161160304); 澳门科学技术发展基金与国家自然科学基金委员会联合资助项目(0069/2021/AFJ)

Enzymatic Preparation and Immunomodulatory Mechanism of Oligosaccharide from Caulerpa racemosa var. peltate

ZENG Jinzi, LIN Qianmin, XU Jingyi, XU Baojun, Io Nam Wong, HUANG Riming   

  1. (1. College of Food Science, South China Agricultural University, Guangzhou 510642, China; 2. Department of Life Science, BNU-HKBU United International College, Zhuhai 519087, China; 3. Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China)
  • Online:2024-09-15 Published:2024-09-09

摘要: 将总状蕨藻盾叶变种多糖经乳糖酶酶解、膜过滤、透析和冻干制备获得总状蕨藻盾叶变种寡糖(Caulerpa racemosa var. peltate oligosaccharide,CRVO-G),测定CRVO-G的相对分子质量与单糖组成,评价CRVO-G的免疫调节活性,并对其作用机制展开研究。结果显示,CRVO-G主要是由相对分子质量分别为617.115、621.081和995.368的2 种四糖和1 种六糖组成的寡糖混合物,主要由半乳糖(51.0%)、甘露糖(21.3%)、葡萄糖(11.5%)、木糖(6.5%)、鼠李糖(2.3%)、葡萄糖醛酸(2.0%)、盐酸氨基葡萄糖(1.8%)、岩藻糖(0.8%)、盐酸氨基半乳糖(0.7%)、半乳糖醛酸(0.7%)、甘露糖醛酸(0.7%)和阿拉伯糖(0.6%)组成。此外,CRVO-G具有良好的免疫调节活性,能促进一氧化氮(NO)和免疫因子的释放,如白细胞介素-1β、白细胞介素-6和肿瘤坏死因子-α。代谢组学和蛋白免疫印迹结果表明,CRVO-G可以促进巨噬细胞花生四烯酸代谢通路中血栓素A2和15-酮前列腺素F2α的合成,提高环氧合酶-2(cyclooxygenase-2,COX-2)、诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)和核因子κB(nuclear factor κB,NF-κB)的磷酸化蛋白的表达水平。研究表明,在巨噬细胞RAW264.7细胞中CRVO-G通过NF-κB/iNOS/COX-2途径发挥免疫调节作用。

关键词: 总状蕨藻盾叶变种;寡糖;酶解;免疫调节;分子机制

Abstract: In this study, oligosaccharide from Caulerpa racemosa var. peltate (CRVO-G) was prepared by sequential enzymatic hydrolysis with lactase, membrane filtration, dialysis, and freeze-drying, and the relative molecular mass and monosaccharide composition of CRVO-G were measured. Meanwhile, the immunoregulatory activity of CRVO-G was evaluated and its mechanism of action was studied. The results showed that CRVO-G was a mixture of two tetrasaccharides and one hexasaccharide with relative molecular masses of 617.115, 621.081, and 995.368, and was mainly composed of galactose (51.0%), mannose (21.3%), glucose (11.5%), xylose (6.5%), rhamnose (2.3%), glucuronic acid (2.0%), glucosamine hydrochloride (1.8%), fucose (0.8%), glucosamine hydrochloride (0.7%), galacturonic acid (0.7%), mannuronic acid (0.7%), and arabinose (0.6%). In addition, CRVO-G had good immunomodulatory activity, as manifested by increased release of nitric oxide and cytokines (interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α). The results of metabolomics analysis and Western blot showed that CRVO-G could promote the synthesis of thromboxane A2 (TXA2) and 15-keto prostaglandin F2α (15-keto-PGF2α) in the arachidonic acid pathway of macrophages, and increase the expression levels of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and the phosphorylation of nuclear factor κB (NF-κB). In summary, CRVO-G exerts immunomodulatory effects by the NF-κB/iNOS/COX-2 pathway in RAW264.7 macrophages.

Key words: Caulerpa racemosa var. peltate; oligosaccharide; enzymatic hydrolysis; immunomodulatory; molecular mechanism

中图分类号: